Cannabidiol Is a Novel Modulator of Bacterial Membrane Vesicles
ORIGINAL RESEARCH
published: 10 September 2019
doi: 10.3389/fcimb.2019.00324
Cannabidiol Is a Novel Modulator of
Bacterial Membrane Vesicles
Uchini S. Kosgodage 1 , Paul Matewele 1 , Brigitte Awamaria 1 , Igor Kraev 2 , Purva Warde 3 ,
Giulia Mastroianni 4 , Alistair V. Nunn 5 , Geoffrey W. Guy 6 , Jimmy D. Bell 5 , Jameel M. Inal 3
and Sigrun Lange 7*
1
Cellular and Molecular Immunology Research Centre, School of Human Sciences, London Metropolitan University, London,
United Kingdom, 2 School of Life, Health and Chemical Sciences, The Open University, Milton Keynes, United Kingdom,
3
Bioscience Research Group, Extracellular Vesicle Research Unit, School of Life and Medical Sciences, University of
Hertfordshire, Hatfield, United Kingdom, 4 School of Biological and Chemical Sciences, Queen Mary University of London,
London, United Kingdom, 5 Research Centre for Optimal Health, School of Life Sciences, University of Westminster, London,
United Kingdom, 6 GW Pharmaceuticals Research, Cambridge, United Kingdom, 7 Tissue Architecture and Regeneration
Research Group, School of Life Sciences, University of Westminster, London, United Kingdom
Edited by:
Jyl S. Matson,
University of Toledo, United States
Reviewed by:
Medicharla Venkata Jagannadham,
Centre for Cellular Molecular Biology
(CCMB), India
Bo Peng,
Sun Yat-sen University, China
*Correspondence:
Sigrun Lange
Specialty section:
This article was submitted to
Molecular Bacterial Pathogenesis,
a section of the journal
Frontiers in Cellular and Infection
Microbiology
Received: 04 April 2019
Accepted: 28 August 2019
Published: 10 September 2019
Citation:
Kosgodage US, Matewele P,
Awamaria B, Kraev I, Warde P,
Mastroianni G, Nunn AV, Guy GW,
Bell JD, Inal JM and Lange S (2019)
Cannabidiol Is a Novel Modulator of
Bacterial Membrane Vesicles.
Front. Cell. Infect. Microbiol. 9:324.
doi: 10.3389/fcimb.2019.00324
Membrane vesicles (MVs) released from bacteria participate in cell communication and
host-pathogen interactions. Roles for MVs in antibiotic resistance are gaining increased
attention and in this study we investigated if known anti-bacterial effects of cannabidiol
(CBD), a phytocannabinoid from Cannabis sativa, could be in part attributed to effects
on bacterial MV profile and MV release. We found that CBD is a strong inhibitor
of MV release from Gram-negative bacteria (E. coli VCS257), while inhibitory effect
on MV release from Gram-positive bacteria (S. aureus subsp. aureus Rosenbach)
was negligible. When used in combination with selected antibiotics, CBD significantly
increased the bactericidal action of several antibiotics in the Gram-negative bacteria. In
addition, CBD increased antibiotic effects of kanamycin in the Gram-positive bacteria,
without affecting MV release. CBD furthermore changed protein profiles of MVs released
from E. coli after 1 h CBD treatment. Our findings indicate that CBD may pose as a
putative adjuvant agent for tailored co-application with selected antibiotics, depending
on bacterial species, to increase antibiotic activity, including via MV inhibition, and help
reduce antibiotic resistance.
Keywords: bacterial membrane vesicles (MVs), cannabidiol (CBD), antibiotic resistance, gram-negative,
gram-positive, E. coli VCS257, S. aureus subsp. aureus Rosenbach
INTRODUCTION
Outer membrane vesicles (OMVs) and membrane vesicles (MVs) are released from Gram-negative
and Gram-positive bacteria and participate in inter-bacterial communication, including
via transfer of cargo molecules (Dorward and Garon, 1990; Li et al., 1998; Fulsundar
et al., 2014; Jan, 2017; Toyofuku et al., 2019). MVs are released in greater abundance
from Gram-negative, than Gram-positive bacteria and their production seems crucial for
bacterial survival and forms part of the stress response (McBroom and Kuehn, 2007;
Macdonald and Kuehn, 2013; Jan, 2017). Gram-negative bacteria generate, in addition to
common one-bilayer vesicles (OMV), also double-bilayer vesicles (O-IMVs), and in some
stress conditions other types of MVs (Pérez-Cruz et al., 2016) and therefore we will use
the umbrella term “membrane vesicles” (MVs) hereafter. MVs are important in biofilm
formation and dissemination of toxins in the host (Wang et al., 2015; Cooke et al., 2019).
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org
1
September 2019 | Volume 9 | Article 324
Kosgodage et al.
CBD—A Novel Modulator of Bacterial MVs
E. coli and S. aureus cultures were maintained by plating
on Mueller-Hinton agar plates and weekly sub-culturing was
performed according to previously established methods (Iqbal
et al., 2013).
Before MV isolation, all bacterial growth medium (LB broth)
was pre-treated before use by ultracentrifugation at 100,000 g
for 24 h to ensure minimum contamination with extracellular
vesicles (EVs) from the medium (Kosgodage et al., 2017).
For MV isolation, bacteria were grown in EV-free medium
(as described above) for 24 h at 37◦ C, the culture medium
was collected and centrifuged once at 400 g for 10 min for
removal of cells, followed by centrifugation at 4,000 g for 1 h
at 4◦ C to remove cell debris. The resultant supernatant was
then centrifuged for 1 h at 100,000 g at 4◦ C and the isolated
MV pellet was resuspended in Dulbecco’s phosphate buffered
saline (DPBS; ultracentrifuged and sterile filtered using a 0.22 µm
filter) and centrifuged again at 100,000 g for 1 h at 4◦ C. The
resulting MV pellet was sterile filtered (0.45 µm) once and then
resuspended in sterile filtered DPBS. The quantitative yield of
vesicles was ∼6.5 × 109 MVs per liter of culture. The isolated MV
pellets were then either used immediately, or stored at −80◦ C for
further experiments.
MVs participate in host-pathogen interactions (Gurung et al.,
2011; Koeppen et al., 2016; Bitto et al., 2017, 2018; Codemo
et al., 2018; Turner et al., 2018; Cecil et al., 2019) and may also
be involved in antibiotic resistance, for instance by protecting
biofilms from antibiotics via increased vesiculation (Manning
and Kuehn, 2011). Furthermore, MVs from Porphyromonas
gingivalis have been linked to metabolic remodeling in the host
(Fleetwood et al., 2017), while MVs from Neisseria gonorrhoeae
have been shown to target host mitochondria and to induce
macrophage death (Deo et al., 2018). Besides roles for cellular
and bacterial communication, the use of MVs as nano-carriers
for various compounds, including for antibiotic and vaccine
delivery, has also raised considerable interest in the research
community (Gnopo et al., 2017; Rüter et al., 2018; Tan et al., 2018;
Wang et al., 2018).
The regulation of bacterial MV biogenesis and release may
therefore be of great importance, both in relation to interbacterial communication, including biofilm formation, their
host interactions as commensals, as well as in host-pathogen
interactions and in antibiotic resistance.
Cannabidiol (CBD) is a phytocannabinoid from Cannabis
sativa with anti-inflammatory (Martin-Moreno et al., 2011 (...truncated)